文献速递外周动脉疾病

痴呆患者因跛行行血运重建的死亡率和以患者为中心结局更差

Mortality and patient-centered outcomes are worse in patients with dementia undergoing revascularization for claudication.
PubMed 文献 · J Vasc Surg · 2026-02-24

基于OneFlorida+数据集297,060例跛行患者(其中9.3%患ADRD)的队列研究显示,ADRD患者全因死亡率更高(HR 1.1,95%CI 1.05-1.12);接受血运重建者90天再入院率更高(OR 1.9),出院至更高级别护理机构更多(OR 2.1),出院回家更少(OR 0.54)。

要点

  • 跛行合并ADRD患者全因死亡风险更高,无论治疗类型如何。
  • ADRD患者血运重建后90天再入院风险约为无ADRD者的1.9倍。
  • ADRD患者血运重建后出院回家可能性更低,更多转至更高级别护理。

核心结论

  • 在大样本跛行队列中,ADRD患者全因死亡风险更高。
  • 接受血运重建的ADRD患者再入院率更高且更常出院至更高级别护理,与血运重建策略无关。

研究设计与样本

  • 基于OneFlorida+数据集的队列研究,纳入2017年1月1日至2024年1月31日治疗的跛行患者。
  • 总队列297,060例,其中ADRD患者27,621例(9.3%)。
  • 按治疗分为药物治疗、腔内血运重建和开放血运重建三组。

主要发现

  • ADRD患者较无ADRD者更年长(78.6岁 vs 66.1岁;P < .001)且女性比例更高(54.9% vs 48.9%;P < .001)。
  • 总队列中ADRD患者全因死亡率更高(HR 1.1;95%CI 1.05-1.12)。
  • 血运重建患者中,ADRD与无ADRD者住院并发症率相似(OR 0.85;95%CI 0.72-1.01)。
  • ADRD患者90天再入院率更高(OR 1.9;95%CI 1.60-2.15)。
  • ADRD患者更常出院至更高级别护理(OR 2.1;95%CI 1.67-2.73),更少出院回家(OR 0.54;95%CI 0.46-0.64)。

临床怎么用

  • 这些数据可用于患者、家属和医生在跛行治疗前进行共享决策对话。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aims of this study were to describe mortality and patient-centered outcomes in a large cohort of patients with claudication and Alzheimer's disease and related dementias (ADRD) as stratified by treatment type. Claudication and ADRD often coexist owing to shared risk factors. Treatment for claudication is primarily conservative, although revascularization can be considered with quality-of-life-limiting leg symptoms. Mortality risk and patient-centered outcomes in patients with ADRD and claudication have not been described. METHODS: Patients in the OneFlorida+ dataset with and without ADRD treated for claudication from January 1, 2017, to January 31, 2024, were included. The total cohort was separated into three treatment groups: medical therapy, endovascular revascularization, or open revascularization. Cox proportional hazard modeling was used for the impact of ADRD on all-cause mortality in the total cohort. Among patients undergoing endovascular or open revascularization, clinical outcomes were inpatient complications and 90-day readmissions, and patient-centered outcomes were discharge to higher level of care and discharge home. RESULTS: The total cohort for claudication was 297,060 patients and included 27,621 patients (9.3%) with a diagnosis of ADRD. Patients with ADRD were more likely to be older (78.6 years vs 66.1 years; P < .001) and women (54.9% vs 48.9%; P < .001). For the total cohort, all-cause mortality was higher in patients with ADRD regardless of treatment type (hazard ratio, 1.1; 95% confidence interval [CI], 1.05-1.12). For patients who underwent revascularization, patients with ADRD had similar rates of inpatient complications compared with patients without ADRD (odds ratio [OR], 0.85; 95% CI, 0.72-1.01), but had higher rates of 90-day readmissions (OR, 1.9; 95% CI, 1.60-2.15). Patients with ADRD undergoing revascularization were more likely to be discharged to a higher level of care (OR, 2.1; 95% CI, 1.67-2.73) and less likely to be discharged home (OR, 0.54; 95% CI, 0.46-0.64). CONCLUSIONS: In a large cohort of patients with claudication, patients with ADRD demonstrate a higher risk of all-cause mortality. Among patients who undergo revascularization for claudication, patients with ADRD have worse readmission rates and are more often discharged to higher levels of care, regardless of revascularization strategy. These data should be used by patients, their families, and physicians to facilitate shared decision--making conversations before claudication treatment.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Shah KB, Neal D, Scali ST, et al. Mortality and patient-centered outcomes are worse in patients with dementia undergoing revascularization for claudication. J Vasc Surg. 2026. PMID: 41748038. doi:10.1016/j.jvs.2026.02.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。